Evidence map›Paper›PMID 40151845›Full record

ArticleDisease models & mechanisms2025

Patient-specific mutation of contact site protein Tomm70 causes neurodegeneration.

Vranda Garg, Wiebke Möbius, Ralf Heinrich, Torben Ruhwedel, Roshan Priyarangana Perera, Patricia Scholz, Till Ischebeck, Gabriela Salinas, Christian Dullin, Martin C Göpfert and 3 more

Abstract read
In one paragraph

Article in Disease models & mechanisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. From the cytosol to the inner membrane: biogenesis of the mitochondrial carrier family.Protein science : a publication of the Protein Society · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Vranda GargDepartment of Cellular Neurobiology, Georg-August-University Göttingen, 37077 Göttingen, Germany.ORCID 0009-0000-4728-5400
Wiebke MöbiusDepartment of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, 37075 Göttingen, Germany.
Ralf HeinrichDepartment of Cellular Neurobiology, Georg-August-University Göttingen, 37077 Göttingen, Germany.
Torben RuhwedelDepartment of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, 37075 Göttingen, Germany.
Roshan Priyarangana PereraDepartment of Developmental Biochemistry, Georg-August-University Göttingen, 37077 Göttingen, Germany.
Patricia ScholzDepartment of Plant Biochemistry, Albrecht-von-Haller-Institute for Plant Sciences and Gottingen Center for Molecular Biosciences (GZMB) Georg-August-University Göttingen, 37077 Göttingen, Germany.
Till IschebeckDepartment of Plant Biochemistry, Albrecht-von-Haller-Institute for Plant Sciences and Gottingen Center for Molecular Biosciences (GZMB) Georg-August-University Göttingen, 37077 Göttingen, Germany.
Gabriela SalinasInstitute of Human Genetics, University Medical Center, Göttingen Georg-August-University Göttingen, 37073 Göttingen, Germany.
Christian DullinDepartment of Diagnostic and Interventional Radiology, University Medical Center, Göttingen, Georg-August-University Göttingen, 37075 Göttingen, Germany.
Martin C GöpfertDepartment of Cellular Neurobiology, Georg-August-University Göttingen, 37077 Göttingen, Germany.
Jacob EngelmannFaculty of Biology, Bielefeld University33615 Bielefeld, Germany.
Roland DoschInstitute of Human Genetics, University Medical Center, Göttingen Georg-August-University Göttingen, 37073 Göttingen, Germany.
Bart R H GeurtenDepartment of Cellular Neurobiology, Georg-August-University Göttingen, 37077 Göttingen, Germany.ORCID 0000-0002-1816-3241

Funding

Deutsche Forschungsgemeinschaft DO 740/2-3Georg-August-Universität GöttingenGerman Academic Exchange ServiceInternational Research Training Groups 273134146Studienstiftung des Deutschen VolkesUniversitätsmedizin GöttingenUniversity of Otago
6 · The paper itself

Abstract

TOMM70 is a receptor at the contact site between mitochondria and the endoplasmic reticulum, and TOMM70 has been identified as a risk gene for hereditary spastic paraplegia. Furthermore, de novo missense variants of TOMM70 have been identified to cause neurological impairments in two unrelated patients. Here, we show that mutant zebrafish ruehreip25ca also harbour a missense mutation in tomm70, affecting the same conserved isoleucine residue as in one of the human patients. Using this model, we demonstrate how loss of Tomm70 function leads to impairment. At the molecular level, the mutation affected the interaction of Tomm70 with the endoplasmic reticulum protein Lam6, a known sterol transporter. At the neuronal level, the mutation impaired mitochondrial transport to the axons and dendrites, leading to demyelination of large calibre axons in the spinal cord. These neurodegenerative defects in zebrafish were associated with reduced endurance and swimming efficiency, and alterations in the C-start escape response, which correlated with decreased spiking in giant Mauthner neurons. Thus, in zebrafish, a mutation in the endoplasmic reticulum-mitochondria contact site protein Tomm70 recreates some of the neurodegenerative phenotypes characteristic of hereditary spastic paraplegia.

Indexed as

Membrane Transport ProteinsMitochondrial Membrane Transport ProteinsMutationNerve DegenerationNeurodegenerative DiseasesZebrafish ProteinsAmino Acid SequenceAnimalsAxonsDendritesEndoplasmic ReticulumHumansMitochondriaMitochondrial Precursor Protein Import Complex ProteinsMutation, MissenseNeuronsMembrane Transport ProteinsMitochondrial Membrane Transport ProteinsMitochondrial Precursor Protein Import Complex ProteinsZebrafish ProteinsEndoplasmic reticulum-mitochondria contact siteNeurodegenerationTomm70Zebrafish

Identifiers

PMID40151845
PMCPMC12067081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.